Overview

Lubiprostone, Colonic Motility and Sensation

Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
This study is being done to evaluate the effects of lubiprostone, a drug approved and used for constipation, on pattern of contractions of the colon and the colon's sensitivity to distension.
Phase:
Phase 4
Details
Lead Sponsor:
Mayo Clinic
Collaborators:
National Center for Research Resources (NCRR)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Takeda
Treatments:
Lubiprostone